Institutional investors purchased a net $536.0 thousand shares of ICLR during the quarter ended December 2012 and now own 89.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANCEBERNSTEIN LP Bought 985.1 Thousand shares of ICON PLC
BAMCO, INC. Bought 822.8 Thousand shares of ICON PLC
CLEARBRIDGE INVESTMENTS LLC Bought 491.9 Thousand shares of ICON PLC